Skip to content

Amedica Drug Screen Test Cup

by Amedica Biotech, Inc.

510(k) K082898

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

2 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK082898 Date19 Dec 2008ClearedStatusActive

Recalls

2 recalls · FDA

    • Terminated Z-0270-2019 FDA Class III initiated 30 Sep 2017 on shared 510(k) K082898

    Product was released to market without the adulteration strip included in the product.

    • Terminated Z-2311-2016 FDA Class III initiated 5 Jul 2016 on shared 510(k) K082898

    Branan Medical is recalling the AmediCheck Instant Test Cup, a 5 panel drug cup, because it may erroneously contain 12 panel cups due to a packaging error.

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
NGL
Device Class
Class II
Regulation
21 CFR Part 862.3650
Advisory Committee
Clinical Toxicology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Amedica Drug Screen Test Cup is an in vitro diagnostic device designed for the rapid, qualitative detection of drugs of abuse in human urine. It employs lateral flow immunoassay technology to identify multiple substances, including opiates, cocaine, THC, amphetamines, methamphetamines, PCP, MDMA, barbiturates, and benzodiazepines, among others, based on the provided registration numbers.

This single-use, over-the-counter device is intended for use in clinical toxicology settings. Supplied as a sterile, ready-to-use cup, it requires no additional preparation beyond the introduction of a urine sample. The device is classified as Class II under FDA regulations (regulation number 862.3650) and holds a 510(k) clearance (K082898) for substantial equivalence, ensuring compliance with FDA standards for in vitro diagnostic devices.

Other devices from Amedica Biotech, Inc.

See all devices from Amedica Biotech, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What substances does the Amedica Drug Screen Test Cup detect in urine samples, and how does it work?

    The Amedica Drug Screen Test Cup uses lateral flow immunoassay technology to rapidly and qualitatively detect multiple drugs of abuse in human urine, including opiates, cocaine, THC, amphetamines, methamphetamines, PCP, MDMA, barbiturates, and benzodiazepines. It provides a simple, no-prep solution by requiring only the introduction of a urine sample into the sterile, ready-to-use cup for results.

  • Is the Amedica Drug Screen Test Cup intended for single-use or reusable applications?

    The Amedica Drug Screen Test Cup is explicitly designed for single-use only. Each cup is sterile and ready-to-use, eliminating the need for preparation or reuse, which helps ensure accuracy and prevent cross-contamination in clinical toxicology settings.

  • How should the Amedica Drug Screen Test Cup be stored, and does it require any special handling?

    While the device is supplied sterile and ready-to-use, storage conditions are not explicitly detailed in the provided data. However, as a single-use, over-the-counter diagnostic tool, it should be stored in a clean, dry environment away from direct sunlight or extreme temperatures to maintain its integrity until use.

  • What regulatory pathway was followed for FDA clearance of this device, and what does that mean for its use?

    The Amedica Drug Screen Test Cup received FDA 510(k) clearance (K082898) under the Traditional 510(k) review pathway, demonstrating substantial equivalence to a predicate device. This clearance confirms compliance with FDA standards for in vitro diagnostic devices classified as Class II, ensuring its suitability for clinical toxicology applications as intended.